David Moatazedi's Net Worth

$11.5 Million

Estimate Recalculated Jul 3, 2024 07:21PM EST

Who is David Moatazedi?

David Moatazedi has an estimated net worth of $11.5 Million. This is based on reported shares across multiple companies, which include Evolus, Inc., OBALON THERAPEUTICS INC, and BIOMERICA INC.

SEC CIK

David Moatazedi's CIK is 0001700836

Past Insider Trading and Trends

2023 was David Moatazedi's most active year for acquiring shares with 7 total transactions. David Moatazedi's most active month to acquire stocks was the month of December. 2023 was David Moatazedi's most active year for disposing of shares, totalling 5 transactions. David Moatazedi's most active month to dispose stocks was the month of July. 2018 saw David Moatazedi paying a total of $8,605,098.32 for 1,345,567 shares, this is the most they've acquired in one year. In 2022 David Moatazedi cashed out on 99,397 shares for a total of $1,194,528.74, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Evolus, Inc. (EOLS) Snapshot price: $13.1

See Remarks

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-20.82%
-140.21K
$9.59
-$3,876,966.91
533.35K
Jun 4 - Jun 6
Form 4
-2.33%
-16.05K
$12.72
-$204,126.99
673.56K
May 10
Form 4
-0.90%
-6.24K
$13.86
-$86,430.96
689.61K
Mar 27
Form 4
-12.19%
-96.57K
$13.92
-$1,344,604.30
695.85K
Mar 19
Form 4
+7.24%
53.5K
$13.08
-$100,803.73
792.42K
Scheduled
Feb 21 - Feb 22
Form 4
+22.35%
134.98K
—
—
738.92K
Feb 7
Form 4
-12.04%
-82.65K
$9.95
-$822,395.97
603.94K
Dec 6 - Dec 8
Form 4
+12.64%
77.03K
$10.27
-$151,770.06
686.59K
Aug 14 - Aug 16
Form 4
—
0
—
—
0
May 8
Form 4
-0.99%
-6.11K
$8.47
-$51,751.70
609.57K
Mar 27
Form 4
-9.44%
-64.21K
$8.47
-$543,796.54
615.68K
Scheduled
Mar 14
Form 4
+38.20%
187.93K
—
—
679.89K
Jan 25
Form 4
-10.11%
-55.32K
$13.64
-$754,307.37
491.96K
May 16
Form 4
-1.10%
-6.10K
$11.62
-$70,928.48
547.28K
Scheduled
Mar 28
Form 4
-6.42%
-37.97K
$9.73
-$369,292.89
553.39K
Scheduled
Mar 8
Form 4
+56.83%
214.29K
—
—
591.36K
Jan 24
Form 4
-15.74%
-70.44K
$11.13
-$783,810.39
377.07K
Aug 13 - Aug 16
Form 4/A
-8.54%
-41.76K
$11.18
-$466,839.34
447.52K
Scheduled
Aug 10
Form 4
+8.54%
41.76K
$11.18
$466,839.34
531.04K
Scheduled
Aug 10
Form 4
+11.09%
48.85K
—
—
489.28K
Mar 26
Form 4
+153.47%
266.67K
—
—
440.43K
Jan 27
Form 4
-4.56%
-8.31K
$7.46
-$61,992.60
173.76K
Scheduled
Jan 25
Form 4
+121.85%
100K
—
—
182.07K
May 13
Form 4
∞
82.07K
—
—
82.07K
Jan 23
Form 4
—
0
—
—
0
Jan 23
Form 4
—
0
—
—
0
May 6
Form 3
—
0
—
—
0
No matching records found

OBALON THERAPEUTICS INC (RSLS) Snapshot price: $0.1987

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+1,422.01%
78.13K
—
—
83.62K
Jul 23
Form 4/A
—
0
—
—
0
Jun 13
Form 4
-50.00%
-5.49K
$1.82
-$9,999.08
5.49K
Aug 23
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
Mar 13
Form 3
—
0
—
—
0
No matching records found

BIOMERICA INC (BMRA) Snapshot price: $0.8729

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Dec 13
Form 4
—
0
—
—
0
Apr 20
Form 3
—
0
—
—
0
No matching records found